Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00149019
Recruitment Status : Withdrawn (the PI is no longer work at Hadassah)
First Posted : September 8, 2005
Last Update Posted : April 8, 2011
Information provided by:
Hadassah Medical Organization

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2005